Amfetamine (International)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N06BA01
CAS registry number (Chemical Abstracts Service)
0000300-62-9
Chemical Formula
C9-H13-N
Molecular Weight
135
Therapeutic Categories
Central stimulant
Sympathomimetic agent, indirect acting
Chemical Name
(RS)-α-Metylphenetylamine (BAN)
Foreign Names
- Amfetaminum (Latin)
- Amfetamin (German)
- Amfétamine (French)
- Anfetamina (Spanish)
Generic Names
- Amfetamina (OS: DCIT)
- Amfetamine (OS: BAN)
- Amphétamine (OS: DCF)
- Amphetamine (IS)
- Benzpropamin (IS)
- CERM 1767 (IS)
- Phenylisopropylamin (IS)
- Racemic Desoxynorephedrine (IS)
- UNII-CK833KGX7E (IS)
- Amfetamine Sulfate (OS: BANM)
- Amphetamine Sulphate (IS)
- Phenaminum (USSRP) (IS)
- Phenylaminopropanum racemicum sulfuricum (IS)
- UNII-6DPV8NK46S (IS)
- Amfetamine Sulfate (PH: BP 2018)
- Amfetamine sulfate (PH: Ph. Eur. 9)
- Amfetamini sulfas (PH: Ph. Eur. 9)
- Amfetaminsulfat (PH: Ph. Eur. 9)
- Amphétamine (sulfate d') (PH: Ph. Eur. 8)
- Amphetamine Sulfate (PH: USP 41)
Brand Names
- Adzenys XR-ODT
Neos, United States - Anfetamina L.CH.
Laboratorio Chile, Chile - Dyanavel XR
Tris Pharma, United States - ACT Amphetamine XR [+ Amfetamine Sulfate, + Dexamfetamine Saccharate, + Dexamfetamine Sulfate]
Actavis Pharma, Canada - Adderall XR [+ Dexamfetamine]
Shire Pharma, Canada - Adderall XR 10 [+ Dexamfetamine]
Shire, United States - Adderall XR 15 [+ Dexamfetamine]
Shire, United States - Adderall XR 20 [+ Dexamfetamine]
Shire, United States - Adderall XR 25 [+ Dexamfetamine]
Shire, United States - Adderall XR 30 [+ Dexamfetamine]
Shire, United States - Adderall XR 5 [+ Dexamfetamine]
Shire, United States - Attent 10mg [+ Dexamfetamine]
Barr Laboratories Inc., Israel - Attent 20mg [+ Dexamfetamine]
Barr Laboratories Inc., Israel - Attent 30mg [+ Dexamfetamine]
Barr Laboratories Inc., Israel - Attent 5mg [+ Dexamfetamine]
Barr Laboratories Inc., Israel - Dextroamp Saccharate, AMP Aspartate, Dextroamp Sulfate and AMP Sulfate [+ Amfetamine]
Sandoz, United States - Dextroamp Saccharate, AMP Aspartate, Dextroamp Sulfate and AMP Sulfate [+ Dexamfetamine]
Actavis, United States; Alvogen, United States; Aurolife, United States; Barr, United States; Epic Pharma, United States; IMPAX Laboratories, United States; Mallinckrodt, United States; Mylan, United States; Sun Pharma, United States; Teva, United States - Mydayis [+ Dextromethorphan]
Shire, United States - PMS-Amphetamines [+ Dexamfetamine]
Pharmascience, Canada - Sandoz Amphetamine [+ Dexamfetamine]
Sandoz, Canada - ACT Amphetamine XR [+ Amfetamine Aspartate, + Dexamfetamine Sulfate, + Dexamfetamine Saccharate]
Actavis Pharma, Canada - Evekeo
Arbor Pharmaceuticals, United States
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Further information on drug naming conventions: International Nonproprietary Names.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.